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Abstract 
This technical report describes a dynamic causal model of the spread of coronavirus through a population. 
The model is based upon ensemble or population dynamics that generate outcomes, like new cases and 
deaths over time. The purpose of this model is to quantify the uncertainty that attends predictions of relevant 
outcomes. By assuming suitable conditional dependencies, one can model the effects of interventions (e.g., 
social distancing) and differences among populations (e.g., herd immunity) to predict what might happen 
in different circumstances. Technically, this model leverages state-of-the-art variational (Bayesian) model 
inversion and comparison procedures, originally developed to characterise the responses of neuronal 
ensembles to perturbations. Here, this modelling is applied to epidemiological populations—to illustrate 
the kind of inferences that are supported and how the model per se can be optimised given timeseries data. 
Although the purpose of this paper is to describe a modelling protocol, the results illustrate some interesting 
perspectives on the current pandemic; for example, the nonlinear effects of herd immunity that speak to a 
self-organised mitigation process. 
Key words: coronavirus; epidemiology; compartmental models; dynamic causal modelling; variational; 
Bayesian 
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Introduction 
The purpose of this paper is to show how dynamic causal modelling can be used to make predictions—and 
test hypotheses—about the ongoing coronavirus pandemic (Huang et al., 2020; Wu et al., 2020; Zhu et al., 
2020). It should be read as a technical report1, written for people who want to understand what this kind of 
modelling has to offer (or just build an intuition about modelling pandemics). It contains a sufficient level 
of technical detail to implement the model using Matlab (or its open source version Octave), while 
explaining things heuristically for non-technical readers. The examples in this report are used to showcase 
the procedures and subsequent inferences that can be drawn. Having said this, there are some quantitative 
results that will be of general interest. These results are entirely conditional upon the model used. 
Dynamic causal modelling (DCM) refers to the characterisation of coupled dynamical systems in terms of 
how observable data are generated by unobserved (i.e., latent or hidden) causes (Friston et al., 2003; Moran 
 
1 Prepared as a proof of concept for submission to the SPI-M (https://www.gov.uk/government/groups/scientific-
pandemic-influenza-subgroup-on-modelling) and the RAMP (Rapid Assistance in Modelling the Pandemic) initiative 
(https://royalsociety.org/topics-policy/Health-and-wellbeing/ramp/). 
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et al., 2013). Dynamic causal modelling subsumes state estimation and system identification under one 
Bayesian procedure, to provide probability densities over unknown latent states (i.e., state estimation) and 
model parameters (i.e., system identification), respectively. Its focus is on estimating the uncertainty about 
these estimates to quantify the evidence for competing models, and the confidence in various predictions. 
In this sense, DCM combines data assimilation and uncertainty quantification within the same optimisation 
process. Specifically, the posterior densities (i.e., Bayesian beliefs) over states and parameters—and the 
precision of random fluctuations—are optimised by maximising a variational bound on the model’s 
marginal likelihood, also known as model evidence. This bound is known as variational free energy or the 
evidence lower bound (ELBO)  in machine learning (Friston et al., 2007; Hinton and Zemel, 1993; MacKay, 
1995; Winn and Bishop, 2005). 
Intuitively, this means one is trying to optimise probabilistic beliefs—about the unknown quantities 
generating some data—such that the (marginal) likelihood of those data is as large as possible. The marginal 
likelihood2 or model evidence can always be expressed as accuracy minus complexity. This means that the 
best models provide an accurate account of some data as simply as possible. Therefore, the model with the 
highest evidence is not necessarily a description of the process generating data: rather, it is the simplest 
description that provides an accurate account of those data. In short, it is ‘as if’ the data were generated by 
this kind of model. Importantly, models with the highest evidence will generalise to new data and preclude 
overfitting, or overconfident predictions about outcomes that have yet to be measured. In light of this, it is 
imperative to select the parameters or models that maximise model evidence or variational free energy (as 
opposed to goodness of fit or accuracy). However, this requires the estimation of the uncertainty about 
model parameters and states, which is necessary to evaluate the (marginal) likelihood of the data at hand. 
This is why estimating uncertainty is crucial. Being able to score a model—in terms of its evidence—means 
that one can compare different models of the same data. This is known as Bayesian model comparison and 
plays an important role when testing different models or hypotheses about how the data are caused. We will 
see examples of this later. This aspect of dynamic causal modelling means that one does not have to commit 
to a particular form (i.e., parameterisation) of a model. Rather, one can explore a repertoire of plausible 
models and let the data decide which is the most apt. 
Dynamic causal models are generative models that generate consequences (i.e., data) from causes (i.e., 
hidden states and parameters). The form of these models can vary depending upon the kind of system at 
hand. Here, we use a ubiquitous form of model; namely, a mean field approximation to loosely coupled 
ensembles or populations. In the neurosciences, this kind of model is applied to populations of neurons that 
respond to experimental stimulation (Marreiros et al., 2009; Moran et al., 2013). Here, we use the same 
mathematical approach to model a population of individuals and their response to an epidemic. The key 
idea behind these (mean field) models is that the constituents of the ensemble are exchangeable; in the sense 
that sampling people from the population at random will give the same average as following one person 
 
2 The marginal likelihood is the likelihood having marginalised (i.e., averaged) over unknown quantities like states 
and parameters: i.e., the probability of having observed some data under a particular model. 
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over a long period of time. Under this assumption3, one can then work out, analytically, how the probability 
distribution over various states of people evolve over time, e.g., whether someone was infected or not. This 
involves parameterising the probability that people will transition from one state to another. By assuming 
the population is large, one can work out the likelihood of observing a certain number of people who were 
infected, given the probabilistic state of the population at that point in time. In turn, one can work out the 
probability of a sequence or timeseries of new cases. This is the kind of generative model used here, where 
the latent states were chosen to generate the data that are—or could be—used to track a pandemic. Figure 
1 provides an overview of this model. In terms of epidemiological models, this can be regarded as an 
extended SEIR (susceptible, exposed, infected and recovered) compartmental model (Kermack et al., 1997). 
Please see (Kucharski et al., 2020) for an application of this kind of model to COVID-194. 
There are number of advantages to using a model of this sort. First, it means that one can include every 
variable that ‘matters’, such that one is not just modelling the spread of an infection but an ensemble 
response in terms of behaviour (e.g., social distancing). This means that one can test hypotheses about the 
contribution of various responses that are installed in the model—or what would happen under a different 
kind of response. A second advantage of having a generative model is that one can evaluate its evidence in 
relation to alternative models, and therefore optimise the structure of the model itself. For example, does 
social distancing behaviour depend upon the number of people who are infected? Or, does it depend on 
how many people have tested positive for COVID-19? (this question is addressed below). A third advantage 
is more practical, in terms of data analysis: because we are dealing with ensemble dynamics, there is no 
need to create multiple realisations or random samples to estimate uncertainty. This is because the latent 
states are not the states of an individual but the sufficient statistics of a probability distribution over 
individual states. In other words, we replace random fluctuations in hidden states with hidden states that 
parameterise random fluctuations. The practical consequence of this is that one can fit these models quickly 
and efficiently—and perform model comparisons over thousands of models. A fourth advantage is that, 
given a set of transition probabilities, the ensemble dynamics are specified completely. This has the simple 
but important consequence that the only unknowns in the model are the parameters of these transition 
probabilities. Crucially, in this model, these do not change with time. This means that we can convert what 
would have been a very complicated, nonlinear state space model for data assimilation into a nonlinear 
mapping from some unknown (probability transition) parameters to a sequence of observations. We can 
therefore make precise predictions about the long-term future, under particular circumstances. This follows 
because the only uncertainty about outcomes inherits from the uncertainty about the parameters, which do 
not change with time. These points may sound subtle; however, the worked examples below have been 
chosen to illustrate these properties.  
 
3 Technically, this property reflects ergodicity that is a consequence of a weakly mixing system: Birkhoff, G.D., 1931. 
Proof of the ergodic theorem. Proc Natl Acad Sci USA 17, 656-660. Having said this, this model aims to make 
ensemble level predictions. Because ergodicity may not necessarily hold in reality, the ensemble level projections 
should not be interpreted as predictions for individual experiences of the epidemic 
4 Conventional (e.g., SEIR) compartmental models in epidemiology usually consider a single attribute of the 
population (e.g., infection status), such that the distribution over all states sums to one. In contrast, the DCM used in 
this work considers multiple attributes, where both the joint and marginal distributions (over each factor) sum to one. 
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This technical report comprises four sections. The first details the generative model, with a focus on the 
conditional dependencies that underwrite the ensemble dynamics generating outcomes. The outcomes in 
question here pertain to a regional outbreak. This can be regarded as a generative model for the first wave 
of an epidemic in a large city or metropolis. This section considers variational model inversion and 
comparison, under hierarchical models. In other words, it considers the distinction between (first level) 
models of an outbreak in one country and (second level) models of differences among countries, in terms 
of model parameters. The second section briefly surveys the results of second level (between-country) 
modelling, looking at those aspects of the model that are conserved over countries (i.e., random effects) 
and those which are not (i.e., fixed effects). The third section then moves on to the dynamics and predictions 
for a single country; here, the United Kingdom. It considers the likely outcomes over the next few weeks 
and how confident one can be about these outcomes, given data from all countries to date. This section 
drills down on the parameters that matter in terms of affecting death rates. It presents a sensitivity analysis 
that establishes the contribution of parameters or causes in the model to eventual outcomes. It concludes by 
looking at the effects of social distancing and herd immunity. The final section concludes with a 
consideration of predictive validity by comparing predicted and actual outcomes. 
 
FIGURE 1 
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Figure 1: generative model. This figure is a schematic description of the generative model used in subsequent 
analyses. In brief, this compartmental model generates timeseries data based on a mean field approximation to 
ensemble or population dynamics. The implicit probability distributions are over four latent factors, each with four 
levels or states. These factors are sufficient to generate measurable outcomes; for example, the number of new cases 
or the proportion of people infected. The first factor is the location of an individual, who can be at home, at work, in 
a critical care unit (CCU) or in the morgue. The second factor is infection status; namely, susceptible to infection, 
infected, infectious or immune. This model assumes that there is a progression from a state of susceptibility to 
immunity, through a period of (pre-contagious) infection to an infectious (contagious) status. The third factor is 
clinical status; namely, asymptomatic, symptomatic, acute respiratory distress syndrome (ARDS) or deceased. Again, 
there is an assumed progression from asymptomatic to ARDS, where people with ARDS can either recover to an 
asymptomatic state or not. Finally, the fourth factor represents diagnostic or testing status. An individual can be 
untested or waiting for the results of a test that can either be positive or negative. With this setup, one can be in one of 
four places, with any infectious status, expressing symptoms or not, and having test results or not. Note that—in this 
construction—it is possible to be infected and yet be asymptomatic. However, the marginal distributions are not 
independent, by virtue of the dynamics that describe the transition among states within each factor. Crucially, the 
transitions within any factor depend upon the marginal distribution of other factors. For example, the probability of 
becoming infected, given that one is susceptible to infection, depends upon whether one is at home or at work. 
Similarly, the probability of developing symptoms depends upon whether one is infected or not. The probability of 
testing negative depends upon whether one is susceptible (or immune) to infection, and so on. Finally, to complete the 
circular dependency, the probability of leaving home to go to work depends upon the number of infected people in 
the population, mediated by social distancing. The curvilinear arrows denote a conditioning of transition probabilities 
on the marginal distributions over other factors. These conditional dependencies constitute the mean field 
approximation and enable the dynamics to be solved or integrated over time. At any point in time, the probability of 
being in any combination of the four states determines what would be observed at the population level. For example, 
the occupancy of the deceased level of the clinical factor determines the current number of people who have recorded 
deaths. Similarly, the occupancy of the positive level of the testing factor determines the expected number of positive 
cases reported. From these expectations, the expected number of new cases per day can be generated. A more detailed 
description of the generative model—in terms of transition probabilities—can be found in in the main text.  
The generative model 
This section describes the generative model summarised schematically in Figure 1, while the data used to 
invert or fit this model are summarised in Figure 2. These data comprise global (worldwide) timeseries 
from countries and regions from the initial reports of positive cases in China to the current day5. 
 
 
5 These data are available from: https://github.com/CSSEGISandData/COVID-19. 
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FIGURE 2 
Figure 2: timeseries data. This figure provides a brief overview of the timeseries used for subsequent modelling, 
with a focus on the early trajectories of mortality. The upper left panel shows the distribution, over countries, of the 
number of days after the onset of an outbreak—defined as 8 days before more than one case was reported. At the time 
of writing (4th April 2020), a substantial number of countries witnessed an outbreak lasting for more than 60 days. The 
upper right panel plots the total number of deaths against the durations in the left panel. Those countries whose 
outbreak started earlier have greater cumulative deaths. The middle left panel plots the new deaths reported (per day) 
over a 48-day period following the onset of an outbreak. The colours of the lines denote different countries. These 
countries are listed in the lower left panel, which plots the cumulative death rate. China is clearly the first country to 
be severely affected, with remaining countries evincing an accumulation of deaths some 30 days after China. The 
middle right panel is a logarithmic plot of the total deaths against population size in the initial (48-day) period. 
Interestingly, there is little correlation between the total number of deaths and population size. However, there is a 
stronger correlation between the total number of cases reported (within the first 48 days) and the cumulative deaths as 
shown in lower right panel. In this period, Germany has the greatest ratio of total cases to deaths. Countries were 
included if their outbreak had lasted for more than 48 days and more than 16 deaths had been reported. The timeseries 
were smoothed with a Gaussian kernel (full width half maximum of two days) to account for erratic reporting (e.g., 
recording deaths over the weekend). 
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The generative model is a mean field model of ensemble dynamics. In other words, it is a state space model 
where the states correspond to the sufficient statistics (i.e., parameters) of a probability distribution over 
the states of an ensemble or population—here, a population of people who are in mutual contact at some 
point in their daily lives. This kind of model is used routinely to model populations of neurons, where the 
ensemble dynamics are cast as density dynamics, under Gaussian assumptions about the probability 
densities; e.g., (Marreiros et al., 2009). In other words, a model of how the mean and covariance of a 
population affects itself and the means and covariances of other populations. Here, we will focus on a single 
population and, crucially, use a discrete state space model. This means that we will be dealing with the 
sufficient statistics (i.e. expectations) of the probability of being in a particular state at any one time. This 
renders the model a compartmental model (Kermack et al., 1997), where each state corresponds to a 
compartment. These latent states evolve according to transition probabilities that embody the causal 
influences and conditional dependencies that lend an epidemic its characteristic form. Our objective is to 
identify the right conditional dependencies—and form posterior beliefs about the model parameters that 
mediate these dependencies. Having done this, we can then simulate an entire trajectory into the distant 
future, even if we are only given data about the beginning of an outbreak6. 
The model considers four different sorts of states (i.e., factors) that provide a description of any individual—
sampled at random—that is sufficient to generate the data at hand. In brief, these factors were chosen to be 
as conditionally independent as possible to ensure an efficient estimation of the model parameters7. The 
four factors were an individual's location, infection status, clinical status and diagnostic status. In other 
words, we considered that any member of the population can be characterised in terms of where they were, 
whether they were infected, infectious or immune, whether they were showing mild and severe or fatal 
symptoms, and whether they had been tested with an ensuing positive or negative result. Each of these 
factors had four levels. For example, the location factor was divided into home, work, critical care unit, 
and the morgue. These states should not be taken too literally. For example, home stands in for anywhere 
that has a limited risk of exposure to, or contact with, an infected person (e.g., in the domestic home, in a 
non-critical hospital bed, in a care home, etc). Work stands in for anywhere that has a larger risk of exposure 
to—or contact with—an infected person and therefore covers non-work activities, such as going to the 
supermarket or participating in team sports. Similarly, designating someone as severely ill with acute 
respiratory distress syndrome (ARDS) is meant to cover any life-threatening conditions that would invite 
admission to intensive care. 
Having established the state space, we can now turn to the causal aspect of the dynamic causal model. The 
causal structure of these models depends upon the dynamics or transitions from one state or another. It is 
at this point that a mean field approximation can be used. Mean field approximations are used widely in 
physics to approximate a full (joint) probability density with the product of a series of marginal densities 
(Bressloff and Newby, 2013; Marreiros et al., 2009; Schumacher et al., 2015; Zhang et al., 2018). In this 
 
6 Note that part of the uncertainty about latent states inherits from uncertainty about how outcomes are generated; for 
example, uncertainty about whether reported death rates are a true reflection of actual death rates. 
7 This involves examining the eigenvectors of the posterior correlation matrix, to preclude marked posterior 
correlations. 
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case, the factorisation is fairly subtle: we will factorise the transition probabilities, such that the probability 
of moving among states—within each factor—depends upon the marginal distribution of other factors (with 
one exception). For example, the probability of developing symptoms when asymptomatic depends on, and 
only on, the probability that I am infected. In what follows, we will step through the conditional probabilities 
for each factor to show how the model is put together (and could be changed). 
 
Transition probabilities and priors 
The first factor has four levels, home, work, CCU and the morgue. People can leave home but will always 
return (with unit probability) over a day. The probability of leaving home has a (prior) baseline rate of one 
third but is nuanced by any social distancing imperatives. These imperatives are predicated on the 
proportion of the population that is currently infected, such that the social distancing parameter (an 
exponent) determines the probability of leaving home8. For example, social distancing is modelled as the 
propensity to leave home and expose oneself to interpersonal contacts. This can be modelled with the 
following transition probability: 
1( | , ) (1 )
sdeinf
t t t t out infectedP loc work loc home clin asymptomatic p
+ = = = = −      (1.1) 
This means that the probability of leaving home, given I have no symptoms, is the probability I would have 
gone out normally, multiplied by a decreasing function of the proportion of people in the population who 
are infected. Formally, this proportion is the marginal probability of being infected, where the marginal 
probability of a factor is an average over the remaining factors. The marginal probability p of the location 
factor is as follows: 
( , , , )
1
[ , , , ]
[ , , , ]
[ , ,
ijk
ijkijk
uu
loc loc loc loc loc
home work CCU morgue
inf inf inf inf inf
susceptible infected infectious immune
clin clin clin
asymptomatic symptomatic
p P loc inf i clin j test k
p p
p
p p p p p
p p p p p
p p p p
= = = = =
=
=
=
=
=


, ]
[ , , , ]
clin clin
ADRS deceased
test test test test test
untested waiting positive negative
p
p p p p p=
        (1.2) 
Where the final four equalities define each factor or state in the model. The parameters in this social 
 
8 We will license this assumption using Bayesian model comparison later. 
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distancing model are the probability of leaving home every day ( )out  and the social distancing exponent 
( )sde . 
The only other two places one can be are in a CCU or the morgue. The probability of moving to critical 
care depends upon bed (i.e., hospital) availability, which is modelled as a sigmoid function of the occupancy 
of this state (i.e., the probability that a CCU bed is occupied) and a bed capacity parameter (a threshold). If 
one has severe symptoms, then one stays in the CCU. Finally, the probability of moving to the morgue 
depends on, and only on, being deceased. Note that all these dependencies are different states of the clinical 
factor (see below). This means we can write the transition probabilities among the location factor for each 
level of the clinical factor as follows (with a slight abuse of notation): 
( )
( )
( )
1
1
1
1
(1 )
( , )
1 1 1
| ,
1
1 1 1
| ,
1
1 1
| ,
1
1
| ,
sdeinf
out infected
loc
CCU cap
t t t
t t t
t t t
t t
P p
Q p
P
P
P loc loc clin asymptomatic
P loc loc clin symptomatic
Q Q
P loc loc clin ARDS
Q Q
P loc loc

 
+
+
+
+
= −
=
− 
 
 = =
 
 
 
 
 
 = =
 
 
 
− − 
 
 = =
 
 
 
( )
1 1 1 1
tclin deceased
 
 
 = =
 
 
 
      (1.3) 
Here, the columns and rows of each transition probability matrix are ordered: home, work, CCU, morgue. 
The column indicates the current location and the row indicates the next location. Parameter 
cap  is bed 
capacity threshold and 
4( 1) 1( , ) (1 e )
s
s  
− −= +  is a decreasing sigmoid function. In brief, these transition 
probabilities mean that I will go out when asymptomatic, unless social distancing is in play. However, when 
I have symptoms I will stay at home, unless I am hospitalised with acute respiratory distress. I remain in 
critical care unless I recover and go home or die and move to the morgue, where I stay. Technically, the 
morgue is an absorbing state. 
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In a similar way, we can express the probability of moving between different states of infection (i.e., 
susceptible, infected, infectious and immune) as follows: 
( )
( )
( )
1
1
1
(1 )
1
| ,
1
1 1
1
| ,
1
1 1
1
| ,
1
Rin
Rin
Rou
Rou
inf
trn infectious
inf
t t t
inf con
con
inf
t t t
inf con
con
inf
t t t
inf c
P p
P
P
P inf inf loc home
P
P
P inf inf loc work
P inf inf loc CCU






 


 


 
+
+
+
= − 
 
 
− = =
 −
 
−  
 
 
− = =
 −
 
−  
= =
−
( )1
1 1
| ,
1 1 1 1
on
con
t t tP inf inf loc morgue

+
 
 
 
 
 
− 
 
 
 = =
 
 
 
     (1.4) 
These transition probabilities mean that when susceptible, the probability of becoming infected depends 
upon the number of social contacts—which depends upon the proportion of time spent at home. This 
dependency is parameterised in terms of a transition probability per contact (θtrn) and the expected number 
of contacts at home (θRin) and work (θRou)9. Once infected, one remains in this state for a period of time that 
is parameterised by a transition rate (θinf). This parameterisation illustrates a generic property of transition 
probabilities; namely, an interpretation in terms of rate constants and, implicitly, time constants. The rate 
parameter θ is related to the rate constant κ and time constant τ according to: 
1exp( ) exp( ) 1: 0

  = − = −             (1.5) 
In other words, the probability of staying in any one state is determined by the characteristic length of time 
that state is occupied. This means that the rate parameter above can be specified, a priori, in terms of the 
 
9 Here, (1 )inftrn infectiousP p= −   can be interpreted as a probability of eluding infection with each interpersonal contact, 
such that the probability of remaining uninfected after 
R  contacts is given by 
RP

. Note, that there is no distinction 
between people at home and at work; both are equally likely to be infectious. 
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number of days we expect people to be infected, before becoming infectious. Similarly, we can parameterise 
the transition from being infectious to being immune in terms of a typical period of being contagious, 
assuming that immunity is enduring and precludes reinfection10. Note that in the model, everybody in the 
morgue is treated as having has acquired immunity. The transitions among clinical states depend upon both 
the infection status and location as follows: 
( )
( )
1
1
1
1 1 1
| , { , }
1
1 (1 )(1 ) (1 )(1 )
| , { , }
(1 )
(1
fat
fat
sur
t t t
dev sym sev rds fat
dev sym
t t t
sym sev rds
rds
loc CCU
loc CCU
P clin clin inf susceptible immune
P clin clin inf infected infectious



    
 
  

+
+
=
= 
− 
 
 
  =
 
 
 
− − − − −
 =
−
− ) 1fat
 
 
 
 
 
  
  (1.6) 
The transitions among clinical states (i.e., asymptomatic, symptomatic, ARDS and deceased) are relatively 
straightforward: if I am not infected (i.e., susceptible or immune) I will move to the asymptomatic state, 
unless I am dead. However, if I am infected (i.e., infected or infectious), I will develop symptoms with a 
particular probability (θdev). Once I have developed symptoms, I will remain symptomatic and either recover 
to an asymptomatic state or develop acute respiratory distress with a particular probability (θsev). The 
parameterisation of these transitions depends upon the typical length of time that I remain symptomatic 
(θsym); similarly, when in acute respiratory distress (θrds). However, I may die following ARDS, with a 
probability that depends upon whether I am in a CCU, or elsewhere. This is the exception (mentioned 
above) to the conditional dependencies on marginal densities. Here, the probability of dying (θfat) depends 
on being infected and my location: I am more likely to die of ARDS, if I am not in CCU, where θsur is the 
probability of surviving at home. The implication here is that the transition probabilities depend upon two 
marginal densities, as opposed to one for all the other factors: see the first equality in (1.6). Please refer to 
Table 1 for details of the model parameters. 
Finally, we turn to diagnostic testing status (i.e., untested, waiting or positive versus negative). The 
transition probabilities here are parameterised in terms of test availability (θtft, θsen). and the probability that 
I would have been tested anyway, which is relatively smaller, if I am asymptomatic (θtes). Test availability 
is a decreasing sigmoid function of the number of people who are waiting (with a delay θdel) for their results. 
 
10 Although cases of double positive diagnoses have reported, these may reflect false test results rather than re-infection 
per se. Having said this, it would be straightforward to include a transition from immunity to susceptible, with a 
suitably small transition rate to model the decay of immunity, or viral mutation. Similarly, one can incorporate 
transition from asymptomatic to symptomatic, when immune, to model partial resistance. 
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I can only move from being untested to waiting. After this, I can only go into positive or negative test states, 
depending upon whether I have the virus (i.e., infected or infectious) or not11.  
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| , { , }
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1 1
1
| , { , }
1 1
1
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tes del
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    (1.7) 
We can now assemble these transition probabilities into a probability transition matrix, and iterate from the 
first day to some time horizon, to generate a sequence of probability distributions over the joint space of all 
factors: 
1 ( , )t t tp T p p+ =            (1.8) 
Notice that this is a completely deterministic state space model, because all the randomness is contained in 
the probabilities. Notice also that the transition probability matrix T is both state and time dependent, 
because the transition probabilities above depend on marginal probabilities. Technically, (1.8) is known as 
a master equation (Seifert, 2012; Vespignani and Zapperi, 1998; Wang, 2009) and forms the basis of the 
dynamic part of the dynamic causal model. 
This model of transmission supports an effective reproduction number or rate, R, which summarises how 
many people I am likely to infect, if I am infected. This depends upon the probability that any contact will 
cause an infection, the probability that the contact is susceptible to infection and number of people I contact: 
( )inf loc|infectious loc|infectioustrn susceptible home Rin work Rou conR p p p   =   +        (1.9) 
 
11 Notice that this model is configured for new cases that are reported based on buccal swabs (i.e., am I currently 
infected?), not tests for antibody or immunological status. A different model would be required for forthcoming tests 
of immunity (i.e., have I been infected?). Furthermore, one might consider the sensitivity and specificity of any test 
by including sensitivity and specificity in (1.7). For example, 1 in 3 tests may be false negatives; especially, when 
avoiding bronchoalveolar lavage to minimise risk to clinicians: Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., 
Tan, W., 2020b. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 
Technical report 
 
14 
 
In this approximation, the number of contacts I make is a weighted average of the number of people I could 
infect at home and the number of people I meet outside, per day, times the number of days I am contagious. 
The effective reproduction rate is not a biological rate constant. However, it is a useful epidemiological 
summary statistic that indicates how quickly the disease spreads through a population. When less than one, 
the infection will decay to an endemic equilibrium. We will use this measure later to understand the role of 
herd immunity. 
This completes the specification of the generative model of latent states. A list of the parameters and their 
prior means (and variances) is provided in Table 1. Notice that all of the parameters are scale parameters, 
i.e., they are rates or probabilities that cannot be negative. To enforce these positivity constraints, one 
applies a log transform to the parameters during model inversion or fitting. This has the advantage of being 
able to simplify the numerics using Gaussian assumptions about the prior density (via a lognormal 
assumption). In other words, although the scale parameters are implemented as probabilities or rates, they 
are estimated as log parameters, denoted by ln = . Note that prior variances are specified for log 
parameters. For example, a variance of 1/64 corresponds to a prior confidence interval of ~25% and can be 
considered weakly informative. 
TABLE 1 
Parameters of the COVID-19 model and priors, ( , )N C   
 (NB: prior means are for scale parameters exp( ) = ) 
 
Number Parameter Mean Variance  Description 
1 
n  1 1/4 Number of initial cases 
2 
N  1 1/16 Effective population size (millions) 
3 
m   10
-6 0 Herd immunity (proportion) 
Location     
4 
out  1/3 1/64 Pr(work | home): probability of going out 
5 
sde  32 1/64 Social distancing exponent 
6 
cap  128/100000 1/64 CCU capacity threshold (per capita) 
Infection     
7 
Rin  3 1/64 Effective number of contacts: home 
8 
Rou  48 1/64 Effective number of contacts: work 
9 
trn  1/4 1/64 Pr(contagion | contact) 
10 1exp( )
inf
inf 
 = −  5inf =  1/64 Infected (pre-contagious) period (days) 
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11 1exp( )
con
con 
 = −  3con =  1/64 Infectious (contagious) period (days) 
Clinical      
12 
dev  1/3 1/64 Pr(symptoms | infected) 
13 
sev  1/100 1/64 Pr(ARDS | symptomatic) 
14 1exp( )
sym
sym 
 = −  5sym =  1/64 symptomatic period (days) 
15 1exp( )
rds
rds 
 = −  12rds =  1/64 acute RDS period (days) 
16 
fat  1/3 1/64 Pr(fatality | CCU) 
17 
sur  1/16 1/64 Pr(survival | home) 
Testing     
18 
tft  500/100000 1/64 Threshold: testing capacity (per capita) 
19 
sen  1/100 1/64 Rate:       testing capacity (%) 
20 1exp( )
del
del 
 = −  2del =  1/64 Delay:     testing capacity (days) 
21 
tes  1/8 1/64 Relative Pr(tested | uninfected)  
 
Sources (Huang et al., 2020; Mizumoto and Chowell, 2020; Russell et al., 2020; Verity et al., 2020; Wang et al., 
2020a) and: 
• https://www.statista.com/chart/21105/number-of-critical-care-beds-per-100000-inhabitants/ 
• https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
• http://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/ 
These prior expectations should be read as the effective rates and time constants as they manifest in a real-world 
setting. For example, a three-day period of contagion is shorter than the period that someone might be infectious 
(Wölfel et al., 2020)12, on the (prior) assumption that they will self-isolate, when they realise they could be contagious. 
 
Initial conditions and population size 
Further parameters are required to generate data, such as the size of the population and the number of people 
who are initially infected ( , )N n 
13, which parameterise the initial state of the population (where  denotes 
 
12 Shedding of COVID-19 viral RNA from sputum can outlast the end of symptoms. Seroconversion occurs after 6-
12 days but is not necessarily followed by a rapid decline of viral load. 
13 Table 1 also includes a parameter for the proportion of people who are initially immune, which we will call on later. 
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a Kronecker tensor product):  
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         (1.10) 
These parameters are unknown quantities that have to be estimated from the data; however, we still have 
to specify their prior densities. This begs the question: what kind of population are we trying to model? 
There are several choices here; ranging from detailed grid models of the sort used in weather forecasting 
(Palmer and Laure, 2013) and epidemiologic models (Ferguson et al., 2006). One could use models based 
upon partial differential equations; i.e., (Markov random) field models (Deco et al., 2008). In this technical 
report, we will choose a simpler option that treats a pandemic as a set of linked point processes that can be 
modelled as rare events. In other words, we will focus on modelling a single outbreak in a region or city 
and treat the response of the ‘next city’ as a discrete process post hoc. This simplifies the generative model; 
in the sense we only have to worry about the ensemble dynamics of the population that comprises one city. 
A complimentary perspective on this choice is that we are trying to model the first wave of an epidemic as 
it plays out in the first city to be affected. Any second wave can then be treated as the first wave of another 
city or region. 
Under this choice, the population size can be set, a priori, to 1,000,000; noting that a small city comprises 
(by definition) a hundred thousand people, while a large city can exceed 10 million. Note that this is a prior 
expectation, the effective population size is estimated from the data: the assumption that the effective 
population size reflects the total population of a country is a hypothesis (that we will test later). 
  
The likelihood or observation model 
The outcomes considered in Figure 2 are new cases (of positive tests and deaths) per day. These can be 
generated by multiplying the appropriate probability by the (effective) population size. The appropriate 
probabilities here are just the expected occupancy of positive test and deceased states, respectively. Because 
we are dealing with large populations, the likelihood of any observed daily count has a binomial distribution 
that can be approximated by a Gaussian density14.  
 
14 This likelihood model can be finessed using a negative binomial distribution: MRC Centre for Global Infectious 
Disease Analysis: Report 13 (http://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/. However, 
a binomial is sufficient for our purposes. 
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 − 
=
        (1.11) 
Here, outcomes are counts of rare events with a small probability 1  of occurring in a large population 
of size 1n . For example, the likelihood of observing a timeseries of daily deaths can be expressed as a 
function of the model parameters as follows: 
( ) ( )0 0
6
, , 1
1
| , , | ( , )
(10 )( )
( , )
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T t
clin clin
t N deceased t deceased t
t t t
P O P O O N n I
n p p
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  
 

−
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= =
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
       (1.12) 
The advantage of this limiting (large population) case is that a (variance stabilising) square root transform 
of the data counts renders their variance unity. With the priors and likelihood model in place, we now have 
a full joint probability over causes (parameters) and consequences (outcomes). This is the generative model 
( , ) ( | ) ( )P O P O P  = . One can now use standard variational techniques (Friston et al., 2007) to estimate 
the posterior over model parameters and evaluate a variational bound on the model evidence or marginal 
likelihood. Mathematically, this is expressed as follows: 
( ) ( , )
( ) ( , )
( ) arg max [ , ]
[ln ( | )] [ ( ) || ( )]
[ln ( | ) ln ( ) ln ( )]
ln ( ) [ ( ) || ( | )] ln ( )
Q
accuracy complexity
Q KL
Q
KL
evidence evidencebound
P N C
Q N
Q F Q O
F E P O D Q P
E P O P O Q
P O D Q P O P O
 
 

  
 
 
=
= 
=
= −
= + −
= − 
       (1.13) 
These expressions show that maximising the variational free energy F with respect to an approximate 
posterior ( )Q   renders the Kullback-Leibler (KL) divergence between the true and approximate posterior 
as small as possible. At the same time, the free energy becomes a lower bound on the log evidence. The 
free energy can then be used to compare different models, where any differences correspond to a log Bayes 
factor or odds ratio (Kass and Raftery, 1995; Winn and Bishop, 2005). 
 
Bayesian model comparison 
One may be asking why we have chosen this particular state space and this parameterisation? Are there 
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alternative model structures or parameterisations that would be more fit for purpose? The answer is that 
there will always be a better model, where ‘better’ is a model that has more evidence. This means that the 
model has to be optimised in relation to empirical data. This process is known as Bayesian model 
comparison based upon model evidence (Winn and Bishop, 2005). For example, in the above model we 
assumed that social distancing increases as a function of the proportion of the population who are infected 
(1.1). This stands in for a multifactorial influence on social behaviour that may be mediated in many ways. 
For example, government advice, personal choices, availability of transport, media reports of ‘panic buying’ 
and so on. So, what licenses us to model the causes of social distancing in terms of a probability that any 
member of the population is infected? The answer rests upon Bayesian model comparison. When inverting 
the model using data from countries with more than 16 deaths (see Figure 2), we obtained a log evidence 
(i.e., variational free energy) of -15701 natural units (nats). When replacing the cause of social distancing 
with the probability of encountering someone with symptoms—or the number of people testing positive—
the model evidence fell substantially to -15969 and -15909 nats, respectively. In other words, there was 
overwhelming evidence in favour of infection rates as a primary drive for social distancing, over and above 
alternative models. We will return to the use of Bayesian model comparison later, when asking what factors 
determine differences between each country’s response to the pandemic. 
 
Summary 
Table 1 lists all the model parameters; henceforth, DCM parameters. In total, there are 21 DCM parameters. 
This may seem like a large number to estimate from the limited amount of data available (see Figure 2). 
The degree to which a parameter is informed by the data depends upon how changes in the parameter are 
expressed in data space. For example, increasing the effective population size will uniformly elevate the 
expected cases per day. Conversely, decreasing the number of initially infected people will delay the curve 
by shifting it in time. In short, a parameter can be identified if it has a relatively unique expression in the 
data. This speaks to an important point, the information in the data is not just in the total count—it is in the 
shape or form of the transient15. 
On this view, there are many degrees of freedom in a timeseries that can be leveraged to identify a highly 
parameterised model. The issue of whether the model is over parameterised or under parameterised is 
exactly the issue resolved by Bayesian model comparison; namely, the removal of redundant parameters to 
suppress model complexity and ensure generalisation: see (1.13)16. One therefore requires the best measures 
 
15 A transient here refers to a transient perturbation to a system, characterising a response that evolves over time. 
16 Intuitively, this can be likened to a bat inverting its generative model of the world using the transients created by 
echo location. The shape of the transient contains an enormous amount of information, provided the bat has a good 
model of how echoes are generated. Exactly the same principle applies here: if one can find the right model, one can 
go beyond the immediate information in the data to make some precise inferences—based upon prior beliefs that 
constitute the generative model. This kind of abductive inference speaks to the importance of having a good forward 
or generative model—and the ability to select the best model based upon model evidence. 
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of model evidence. This is the primary motivation for using variational Bayes; here, variational Laplace 
(Friston et al., 2007). The variational free energy, in most circumstances, provides a better approximation 
than alternatives such as the widely used Akaike information criteria and the widely used Bayesian 
information criteria (Penny, 2012). 
One special aspect of the model above is that it has absorbing states. For example, whenever one enters the 
morgue, becomes immune, dies or has a definitive test result, one stays in that state: see Figure 1. This is 
important, because it means the long-term behaviour of the model has a fixed point. In other words, we 
know what the final outcomes will be. These outcomes are known as endemic equilibria. This means that 
the only uncertainty is about the trajectory from the present point in time to the distant future. We will see 
later that—when quantified in terms of Bayesian credible intervals—this uncertainty starts to decrease as 
we go into the distant future. This should be contrasted with alternative models that do not parameterise the 
influences that generate outcomes and therefore call upon exogenous inputs (e.g., statutory changes in 
policy or changes in people's behaviour). If these interventions are unknown, they will accumulate 
uncertainty over time. By design, we elude this problem by including everything that matters within the 
model and parameterising strategic responses (like social distancing) as an integral part of the transition 
probabilities. 
We have made the simplifying assumption that every country reporting new cases is, effectively, reporting 
the first wave of an affected region or city. Clearly, some countries could suffer simultaneous outbreaks in 
multiple cities. This is accommodated by an effective population size that could be greater than the prior 
expectation of 1 million. This is an example of finding a simple model that best predicts outcomes—that 
may not be a veridical reflection of how those outcomes were actually generated. In other words, we will 
assume that each country behaves as if it has a single large city of at-risk denizens. In the next section, we 
look at the parameter estimates that obtain by pooling information from all countries, with a focus on 
between country differences, before turning to the epidemiology of a single country (the United Kingdom). 
Hitherto, we have focused on a generative model for a single city. However, in a pandemic, many cities 
will be affected. This calls for a hierarchical generative model that considers the response of each city at 
the first level and a global response at the second. This is an important consideration because it means, from 
a Bayesian perspective, knowing what happens elsewhere places constraints (i.e., Bayesian shrinkage 
priors) on estimates of what is happening in a particular city. Clearly, this rests upon the extent to which 
certain model parameters are conserved from one city to another—and which are idiosyncratic or unique. 
This is a problem of hierarchical Bayesian modelling or parametric empirical Bayes (Friston et al., 2016; 
Kass and Steffey, 1989). In the illustrative examples below, we will adopt a second level model in which 
key (log) parameters are sampled from a Gaussian distribution with a global (worldwide) mean and 
variance. From the perspective of the generative model, this means that to generate a pandemic, one first 
samples city-specific parameters from a global distribution, adds a random effect, and uses the ensuing 
parameters to generate a timeseries for each city.  
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Parametric empirical Bayes and hierarchical models 
This section considers the modelling of country-specific parameters, under a simple (general linear) model 
of between-country effects. This (second level) model requires us to specify which parameters are shared 
in a meaningful way between countries and which are unique to each country. Technically, this can be cast 
as the difference between random and fixed effects. Designating a particular parameter as a random effect 
means that this parameter was generated by sampling from a countrywide distribution, while a fixed effect 
is unique to each country. Under a general linear model, the distribution for random effects is Gaussian. In 
other words, to generate the parameter for a particular country, we take the global expectation and add a 
random Gaussian variate, whose variance has to be estimated under suitable hyperpriors. Furthermore, one 
has to specify systematic differences between countries in terms of independent variables; for example, 
does the latitude of a country have any systematic effect on the size of the at-risk population? The general 
linear model used here comprises a constant (i.e., the expectation or mean of each parameter over countries), 
the (logarithms of) total population size, and a series of independent variables based upon a discrete sine 
transform of latitude and longitude. The latter variables stand in for any systematic and geopolitical 
differences among countries that vary smoothly with their location. Notice that the total population size 
may or may not provide useful constraints on the effective size of the population at the first level. Under 
this hierarchical model, a bigger country may have a transport and communication infrastructure that could 
reduce the effective (at risk) population size. A hint that this may be the case is implicit in Figure 2, where 
there is no apparent relationship between the early incidence of deaths and total population size. 
In the examples below, we treated the number of initial cases and the parameters pertaining to testing as 
fixed effects and all remaining parameters as random effects. The number of initial infected people 
determines the time at which a particular country evinces its outbreak. Although this clearly depends upon 
geography and other factors, there is no a priori reason to assume a random variation about an average 
onset time. Similarly, we assume that each country’s capacity for testing was a fixed effect; thereby 
accommodating non-systematic testing or reporting strategies17. Note that in this kind of modelling, 
outcomes such as new cases can only be interpreted in relation to the probability of being tested and the 
availability of tests18. 
 
17 This reflects concerns that data from different countries may not have been acquired or reported using the same 
criteria. 
18 These are two of several factors that conspire to produce the actual outcomes. The purpose of having a generative 
model is that reports of new cases may provide useful constraints on the latent causes of death rates. This means it is 
imperative to model the latent causes that interact in generating one sort of outcome, so that it can inform the causes 
of another. This fusion of different sorts of outcomes is the raison d'être for a generative model, when inferring their 
common underlying causes. 
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With this model in place, we can now use standard procedures for parametric empirical Bayesian modelling 
(Friston et al., 2016; Kass and Steffey, 1989) to estimate the second level parameters that couple between-
country independent variables to country-specific parameters of the DCM. However, there are a large 
number of these parameters—that may or may not contribute to model evidence. In other words, we need 
some way of removing redundant parameters based upon Bayesian model comparison. This calls upon 
another standard procedure called Bayesian model reduction (Friston et al., 2018; Friston et al., 2016). In 
brief, Bayesian model reduction allows one to evaluate the evidence for a model that one would have 
obtained if the model had been reduced by removing one or more parameters. The key aspect of Bayesian 
model reduction is that this evidence can be evaluated using the posteriors and priors of a parent model that 
includes all possible parameters. There are clearly an enormous number of combinations of parameters that 
one could consider. Fortunately, these can be scored quickly and efficiently using Bayesian model 
reduction, by making use of Savage-Dickey density ratios (Friston and Penny, 2011; Savage, 1954). 
Because Bayesian model reduction scores the effect of changing the precision of priors—on model 
evidence—it can be regarded as an automatic Bayesian sensitivity analysis, also known as robust Bayesian 
analysis (Berger, 2011). 
Figure 3 shows the results of this analysis. The upper panels show the posterior probability of 256 models 
that had the greatest evidence (shown as a log posterior in the upper left panel). Each of these models 
corresponds to a particular combination of parameters that have been ‘switched off’, by shrinking their 
prior variance to zero. By averaging the posterior estimates in proportion to the evidence for each model, 
—known as Bayesian model averaging (Hoeting et al., 1999)—we can eliminate redundant parameters and 
thereby provide a simpler explanation for differences among countries. This is illustrated in the lower 
panels, which show the posterior densities before (left) and after (right) Bayesian model reduction. These 
estimates are shown in terms of their expectation or maximum a posteriori (MAP) value (as blue bars), with 
90% Bayesian credible intervals (as pink bars).  
The first 21 parameters are the global expectations of the DCM parameters. The remaining parameters are 
the coefficients that link various independent variables at the second level to the parameters of the transition 
probabilities at the first. Note that a substantial number of second level parameters have been removed; 
however, many are retained. This suggests that there are systematic variations over countries in certain 
random effects at the country level. Figure 4 provides an example based upon the largest effect mediated 
by the independent variables. In this analysis, latitude (i.e., distance from the South Pole) appears to reduce 
the effective size of an at-risk population. In other words, countries in the northern hemisphere have a 
smaller effective population size, relative to countries in the southern hemisphere. Clearly, there may be 
many reasons for this; for example, systematic differences in temperature or demographics.  
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FIGURE 3 
Figure 3: Bayesian model reduction. This figure reports the results of Bayesian model reduction. In this instance, 
the models compared are at the second or between-country level. In other words, the models compared contained all 
combinations of (second level) parameters (a parameter is removed by setting its prior variance to zero). If the model 
evidence increases—in virtue of reducing model complexity—then this parameter is redundant. The upper panels 
show the relative evidence of the most likely 256 models, in terms of log evidence (left panel) and the corresponding 
posterior probability (right panel). Redundant parameters are illustrated in the lower panels by comparing the posterior 
expectations before and after the Bayesian model reduction. The blue bars correspond to posterior expectations, while 
the pink bars denote 90% Bayesian credible intervals. The key thing to take from this analysis is that a large number 
of second level parameters have been eliminated. These second level parameters encode the effects of population size 
and geographical location, on each of the parameters of the generative model. The next figure illustrates the 
nonredundant effects that can be inferred with almost 100% posterior confidence. 
 
FIGURE 4 
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Figure 4: between country effects. This figure shows the relationship between parameters of the generative model 
and the explanatory variables in a general linear model of between country effects. The left panel shows a regression 
of country-specific DCM parameters on the independent variable that had the greatest absolute value; namely, the 
contribution of an explanatory variable to a model parameter. Here, the effective size of the population appears to 
depend upon the latitude of a country. The right panel shows the absolute values of the GLM parameters in matrix 
form, showing that the effective size of the population was most predictable (the largest values are in white), though 
not necessarily predictable by total population size. The red circle highlights the parameter mediating the relationship 
illustrated in the left panel. 
Figure 5 shows the Bayesian parameter averages (Litvak et al., 2015) of the DCM parameters over 
countries. The posterior density (blue bars and pink lines) are supplemented with the prior expectations (red 
bars) for comparison. The upper panel shows the MAP estimates of log parameters, while the lower panel 
shows the same results in terms of scale parameters. The key thing to take from this analysis is the tight 
credible intervals on the parameters, when averaging in this way. According to this analysis, the number of 
effective contacts at home is about three people, while this increases by an order of magnitude to about 30 
people when leaving home. The symptomatic and acute respiratory distress periods have been estimated 
here at about five and 13 days respectively, with a delay in testing of about two days. These are the values 
that provide the simplest explanation for the global data at hand—and are in line with empirical estimates19. 
 
19 MRC Centre for Global Infectious Disease Analysis: Report 13, http://www.imperial.ac.uk/mrc-global-infectious-
disease-analysis/covid-19/. Seth Flaxman, Swapnil Mishra, Axel Gandy et al. Estimating the number of infections and 
the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries. Imperial College London 
(2020). 
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FIGURE 5 
Figure 5: Bayesian parameter averages. This figure reports the Bayesian parameter averages over countries 
following a hierarchical or parametric empirical Bayesian analysis that tests for—and applies shrinkage priors to—
posterior parameter estimates for each country. The upper panel shows the parameters as estimated in log space, while 
the lower panel shows the same results for the corresponding scale (nonnegative) parameters. The blue bars report 
posterior expectations, while the thinner red bars in the upper panel are prior expectations. The pink bars denote 90% 
Bayesian credible intervals. One can interpret these parameters as the average value for any given parameter of the 
generative model, to which a random (country-specific) effect is added to generate the ensemble dynamics for each 
country. In turn, these ensemble distributions determine the likelihood of various outcome measures under large 
number (i.e., Gaussian) assumptions. 
Figure 6 shows the country-specific parameter estimates for 12 of the 21 DCM parameters. These posterior 
densities were evaluated under the empirical priors from the parametric empirical Bayesian analysis above. 
As one might expect—in virtue of the second level effects that survived Bayesian model reduction—there 
are some substantial differences between countries in certain parameters. For example, the effective 
population size in the United States of America is substantially greater than elsewhere at about 25 million 
(the population in New York state is about 19.4 million). The effective population size in the UK 
(dominated by cases in London) is estimated to be about 2.5 million (London has a population of about 7.5 
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million)20. Social distancing seems to be effective and sensitive to infection rates in France but much less 
so in Canada. The efficacy of social distancing in terms of the difference between the number of contacts 
at home and work is notably attenuated in the United Kingdom—that has the greatest number of home 
contacts and the least number of work contacts. Other notable differences are the increased probability of 
fatality in critical care evident in China. This is despite the effective population size being only about 2.5 
million. Again, these assertions are not about actual states of affairs. These are the best explanations for the 
data under the simplest model of how those data were caused. 
 
FIGURE 6 
Figure 6: differences among countries. This figure reports the differences among countries in terms of selected 
parameters of the generative model, ranging from the effective population size, through to the probability of testing 
 
20 https://www.worldometers.info/world-population/uk-population 
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its denizens. The blue bars represent the posterior expectations, while the pink bars are 90% Bayesian credible 
intervals. Notice that these intervals are not symmetrical about the mean because we are reporting scale parameters—
as opposed to log parameters. For each parameter, the countries showing the smallest and largest values are labelled. 
The red asterisk denotes the country considered in the next section (the United Kingdom). The next figure illustrates 
the projections, in terms of new deaths and cases, based upon these parameter estimates. The order of the countries is 
listed in Figure 2. 
 
Summary 
This level of modelling is important because it enables the data or information from one country to inform 
estimates of the first level (DCM) parameters that underwrite the epidemic in another country21. This is 
another expression of the importance of having a hierarchical generative model for making sense of the 
data. Here, the generative model has latent causes that span different countries, thereby enabling the fusion 
of multimodal data from multiple countries (e.g., new test or death rates). Two natural questions now arise. 
Are there any systematic differences between countries in the parameters that shape epidemiological 
dynamics—and what do these dynamics or trajectories look like?  
This concludes our brief treatment of between country effects, in which we have considered the potentially 
important role of Bayesian model reduction in identifying systematic variations in the evolution of an 
epidemic from country to country. The next section turns to the use of hierarchically informed estimates of 
DCM parameters to characterise an outbreak in a single country. 
Dynamic causal modelling of a single country 
This section drills down on the likely course of the epidemic in the UK, based upon the posterior density 
over DCM parameters afforded by the hierarchical (parametric empirical) Bayesian analysis of the previous 
section (listed in Table 2). Figure 7 shows the expected trajectory of death rates, new cases, and occupancy 
of CCU beds over a six-month (180 day) period. These (posterior predictive) densities are shown in terms 
of an expected trajectory and 90% credible intervals (blue line and shaded areas, respectively). The black 
dots represent empirical data (available at the time of writing). Notice that the generative model can produce 
outcomes that may or may not be measured. Here, the estimates are based upon the new cases and deaths 
in Figure 2.  
The panels on the left show that our confidence about the causes of new cases is relatively high during the 
period for which we have data and then becomes uncertain in the future. This reflects the fact that the data 
are informing those parameters that shaped the initial transient, whereas other parameters responsible for 
the late peak and subsequent trajectory are less informed. Notice that the uncertainty about cumulative 
 
21 Or, indeed, a previous pandemic, such as the 2009 H1H1 pandemic. We will return to this in the conclusion. 
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deaths itself accumulates. On this analysis, we can be 90% confident that in five weeks, between 13,000 
and 22,000 people may have died. Relative to the total population, the proportion of people dying is very 
small; however, the cumulative death rates in absolute numbers are substantial, in relation to seasonal 
influenza (indicated with broken red lines). Although cumulative death rates are small, they are 
concentrated within a short period of time, with near-identical CCU needs—with the risk of over-whelming 
available capacity (not to mention downstream effects from blocking other hospital admissions to prioritise 
the pandemic). 
 
FIGURE 7 
Figure 7: projected outcomes. This figure reports predicted22 new deaths and cases (and CCU occupancy) for an 
exemplar country; here, the United Kingdom. The panels on the left show the predicted outcomes as a function of 
 
22 We will use predictions—as opposed to projections—when appropriate, to emphasise the point that the generative 
model is not a timeseries model, in the sense that the unknown quantities (DCM parameters) do not change with time. 
This means the there is uncertainty about predictions in the future and the past, given uncertainty about the parameters 
(see Figure 7). This should be contrasted with the notion of forecasting or projection; however, predictions in the 
future, in this setting, can be construed as projections. 
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weeks. The blue lines correspond to the expected trajectory, while the shaded areas are 90% Bayesian credible 
intervals. The black dots represent empirical data, upon which the parameter estimates are based. The lower right 
panel shows the parameter estimates for the country in question. As in previous figures, the prior expectations are 
shown as pink bars over the posterior expectations (and credible intervals). The upper right panel illustrates the 
equivalent expectations in terms of cumulative deaths. The dotted red lines indicate the number of people who died 
from seasonal influenza in recent years23. The key point to take from this figure is the quantification of uncertainty 
inherent in the credible intervals. In other words, uncertainty about the parameters propagates through to uncertainty 
in predicted outcomes. This uncertainty changes over time because of the nonlinear relationship between model 
parameters and ensemble dynamics. By model design, one can be certain about the final states; however, uncertainty 
about cumulative death rates itself accumulates. The mapping from parameters, through ensemble dynamics to 
outcomes is mediated by latent or hidden states. The trajectory of these states is illustrated in the next figure. 
The underlying latent causes of these trajectories are shown in Figure 8. The upper panels reproduce the 
expected trajectories of the previous figure, while the lower panels show the underlying latent states in 
terms of expected rates or probabilities. For example, the social distancing measures are expressed in terms 
of an increasing probability of being at home, given the accumulation of infected cases in the population. 
During the peak expression of death rates, the proportion of people who are immune (herd immunity) 
increases to about 30% and then asymptotes at about 90%. This period is associated with a marked increase 
in the probability of developing symptoms (peaking at about 11 weeks, after the first reported cases). 
Interestingly, under these projections, the number of people expected to be in critical care should not exceed 
capacity: at its peak, the upper bound of the 90% credible interval for CCU occupancy is approximately 
4200, this is within the current CCU capacity of London (corresponding to the projected capacity of the 
temporary Nightingale Hospital24 in London, UK). 
 
23 Public Health England estimates that on average 17,000 people have died from the flu in England annually between 
2014/15 and 2018/19. However, yearly deaths vary widely, from a high of 28,330 in 2014/15 to a low of 1,692 in 
2018/19 (broken red lines in Figure 7). 
24 Note, only 2800 beds are ventilator/ITU beds. 
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FIGURE 8 
Figure 8: latent causes of observed consequences. The upper panels reproduce the expected trajectories of the 
previous figure, for an example country (here the United Kingdom). The expected death rate is shown in blue, new 
cases in red, predicted recovery rate in orange and CCU occupancy in yellow. The black dots correspond to empirical 
data. The lower four panels show the evolution of latent (ensemble) dynamics, in terms of the expected probability of 
being in various states. The first (location) panel shows that after about 5 to 6 weeks, there is sufficient evidence for 
the onset of an episode to induce social distancing, such that the probability of being found at work falls, over a couple 
of weeks to negligible levels. At this time, the number of infected people increases (to about 32%) with a concomitant 
probability of being infectious a few days later. During this time, the probability of becoming immune increases 
monotonically and saturates at about 20 weeks. Clinically, the probability of becoming symptomatic rises to about 
30%, with a small probability of developing acute respiratory distress and, possibly death (these probabilities are very 
small and cannot be seen in this graph). In terms of testing, there is a progressive increase in the number of people 
tested, with a concomitant decrease in those untested or waiting for their results. Interestingly, initially the number of 
negative tests increases monotonically, while the proportion of positive tests starts to catch up during the peak of the 
episode. Under these parameters, the entire episode lasts for about 10 weeks, or less than three months. The broken 
red line in the upper left panel shows the typical number of CCU beds available to a well-resourced city, prior to the 
outbreak. 
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TABLE 2 
Posterior estimates of key DCM parameters (for the United Kingdom), with 90% credible range 
 
parameter Mean Units Upper Lower 
initial cases 0.33  0.19 0.57 
size of population 2.49 M 1.99 3.11 
Pr(work | home) 17 % 12 23 
social distancing 1.60  1.159 2.2 
contacts: home 7.01  5.49 8.95 
contacts: work 16.02  12.12 21.19 
Pr(contagion | contact) 19 % 15 25 
infected period 6.44 Days 4.87 8.51 
contagious period 2.93 Days 2.15 3.99 
Pr(symptoms | infected) 47 % 34 65 
Pr(ARDS | symptoms) 1.70 % 1.31 2.20 
symptomatic period 3.45 Days 2.55 4.68 
acute RDS period 10.89 Days 8.07 14.70 
Pr(fatality | CCU) 48 % 39 60 
Pr(survival | home) 6.36 % 4.56 8.87 
test delay 2.02 Days 1.668 2.45 
Pr(tested | uninfected) 0.12 % 10 15 
 
It is natural to ask which DCM parameters contributed the most to the trajectories in Figure 8. This is 
addressed using a sensitivity analysis. Intuitively, this involves changing a particular parameter and seeing 
how much it affects the outcomes of interest. Figure 9 reports a sensitivity analysis of the parameters in 
terms of their direct contribution to cumulative deaths (upper panel) and how they interact (lower panel). 
These are effectively the gradient and Hessian matrix (respectively) of predicted cumulative deaths. The 
bars in the upper panel pointing to the left indicate parameters that decrease total deaths. These include 
social distancing and bed availability, which are—to some extent—under our control. Other factors that 
improve fatality rates include the symptomatic and acute respiratory distress periods and the probability of 
surviving outside critical care. These, at the present time, are not so amenable to intervention. Note that 
initial immunity has no effect in this analysis because we clamped the initial values to zero with very precise 
priors. We will relax this later. First, we look at the effect of social distancing by simulating the ensemble 
dynamics under increasing levels of the social distancing exponent (i.e., the sensitivity of our social 
distancing and self-isolation behaviour to the prevalence of the virus in the community). 
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FIGURE 9 
Figure 9: sensitivity analysis. These panels show the change in outcome measures—here cumulative deaths—with 
respect to model parameters (upper panel: first order derivatives. lower panel: second order derivatives). The bar charts 
in the upper panel are the derivatives of outcomes with respect to each of the parameters. Positive values (on the right) 
exacerbate new cases when increased, while negative values (on the left) decrease new cases. As one might expect, 
increasing social distancing, bed availability and the probability of survival outside critical care, tend to decrease death 
rate. Interestingly, increasing both the period of symptoms and ARDS decreases overall death rate, because (in this 
compartmental model) keeping someone alive for longer in a CCU reduces fatality rates (as long as capacity is not 
exceeded). The lower panel shows the second order derivatives. These reflect the effect of one parameter on the effect 
of another parameter on total deaths. For example, the effects of bed availability and fatality in CCU are positive, 
meaning that the beneficial (negative) effects of increasing bed availability—on total deaths—decrease with fatality 
rates. 
It may be surprising to see that social distancing has such a small effect on total deaths (see upper panel in 
Figure 9). However, the contribution of social distancing is in the context of how the epidemic elicits other 
responses; for example, increases in critical care capacity. Quantitatively speaking, increasing social 
distancing only delays the expression of morbidity in the population: it does not, in and of itself, decrease 
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the cumulative cost (although it buys time to develop capacity, treatments, and primary interventions). This 
is especially the case if there is no effective limit on critical care capacity, because everybody who needs a 
bed can be accommodated. This speaks to the interaction between different causes or parameters in 
generating outcomes. In the particular case of the UK, the results in Figure 4 suggest that although social 
distancing is in play, self-isolation appears limited. This is because the number of contacts at home is 
relatively high (at over five); thereby attenuating the effect of social distancing. In other words, slowing the 
spread of the virus depends upon reducing the number of contacts by social distancing. However, this will 
only work if there is a notable difference between the number of contacts at home and work. One can 
illustrate this by simulating the effects of social distancing, when it makes a difference. 
Figure 10 reproduces the results in Figure 8 but for 16 different levels of the social distancing parameter, 
while using the posterior expectation for contacts at home (of about four) from the Bayesian parameter 
average. Social distancing is expressed in terms of the probability of being found at home or work (see the 
panel labelled location). As we increase social distancing the probability and duration of being at home 
during the outbreak increases. This flattens the curve of death rates per day from about 600 to a peak of 
about 400. This is the basis of the mitigation (‘curve flattening’) strategies that have been adopted 
worldwide. The effect of this strategy is to reduce cumulative deaths and prevent finite resources being 
overwhelmed. In this example, from about 17,000 to 14,000, potentially saving about 3000 people. This is 
roughly four times the number of people who die in the equivalent period due to road traffic accidents. 
Interestingly, these (posterior predictive) projections suggest that social distancing can lead to an endgame 
in which not everybody has to be immune (see the middle panel labelled infection). We now look at herd 
immunity using the same analysis. 
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FIGURE 10 
Figure 10: the effects of social distancing. This figure uses the same format as Figure 9. However, here trajectories 
are reproduced under different levels of social distancing; from zero through to four (in 16 steps). This parameter is 
the exponent applied to the probability of not being infected. In other words, it scores the sensitivity of social 
distancing to the prevalence of the virus in the population. In this example (based upon posterior expectations for the 
United Kingdom and Bayesian parameter averages over countries), death rates (per day) decrease progressively with 
social distancing. The cumulative death rate is shown as a function of social distancing in the upper right panel. The 
vertical line corresponds to the posterior expectation of the social distancing exponent for this country. These results 
suggest that social distancing relieves pressure on critical care capacities and ameliorates cumulative deaths by about 
3000 people. Note that these projections are based upon an effective social distancing policy at home, with about four 
contacts. In the next figure, we repeat this analysis but looking at the effect of herd immunity. 
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Figure 11 reproduces the results in Figure 10 using the United Kingdom posterior estimates – but varying 
the initial (herd) immunity over 16 levels from, effectively, 0 to 100%. The effects of herd immunity are 
marked, with cumulative deaths ranging from about 18,000 with no immunity to very small numbers with 
a herd immunity of about 70%. The broken red lines in the upper right panel are the number of people dying 
from seasonal influenza (as in Figure 7). These projections suggest that there is a critical level of herd 
immunity that will effectively avert an epidemic; in virtue of reducing infection rates, such that the spread 
of the virus decays exponentially. If we now return to Figure 8, it can be seen that the critical level of herd 
immunity will, on the basis of these projections, be reached 2 to 3 weeks after the peak in death rates. At 
this point—according to the model—social distancing starts to decline as revealed by an increase in the 
probability of being at work. We will put some dates on this trajectory by expressing it as a narrative in the 
conclusion. 
 
FIGURE 11 
Figure 11: herd immunity. This figure reproduces the format of the previous figure. However, here, we increased 
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the initial proportion of the at-risk population who were initially immune. Increasing the initial immunity dramatically 
decreases death rates with a fall in the cumulative deaths from several thousand to negligible levels with an initial 
herd immunity of about 70%. The dashed lines in the upper panel shows the equivalent deaths over the same time 
period due to seasonal flu (based upon 2014/2014 and 2018/2019 figures). The lower deaths due to seasonal flu would 
require an initial herd immunity of about 60%.  
From a modelling perspective, the influence of initial herd immunity is important because it could form the 
basis of modelling the spread of the virus from city to another—and back again. In other words, more 
sophisticated generative models can be envisaged, in which an infected person from one city is transported 
to another city with a small probability or rate. Reciprocal exchange between cities, (and ensuing ‘second 
waves’) will then depend sensitively on the respective herd immunities in different regions. Anecdotally, 
other major pandemics, without social isolation strategies, have almost invariably been followed by a 
second peak that is as high (e.g., the 2009 H1N1 pandemic), or higher, than the first. Under the current 
model, this would be handled in terms of a second region being infected by the first city and so on; like a 
chain of dominos or the spread of a bushfire (Rhodes and Anderson, 1998; Zhang and Tang, 2016). 
Crucially, the effect of the second city (i.e., wave) on the first will be sensitive to the herd immunity 
established by the first wave. In this sense, it is interesting to know how initial levels of immunity shape a 
regional outbreak, under idealised assumptions. 
Figure 12 illustrates the interaction between immunity and viral spread as characterised by the effective 
reproduction rate, R (a.k.a. number or ratio); see (1.9). This figure plots the predicted death rates for the 
United Kingdom and the accompanying fluctuations in R and herd immunity, where both are treated as 
outcomes of the generative model. The key thing to observe is that with low levels of immunity, R is fairly 
high at around 2.5 (current estimates of the basic reproduction ratio25 R0, in the literature, range from 1.4 to 
3.9). As soon as social distancing comes into play, R falls dramatically to almost 0. However, when social 
distancing is relaxed some weeks later, R remains low due to the partial acquisition of herd immunity, 
during peak of the epidemic. Note that herd immunity in this setting pertains to, and only to, the effective 
or at-risk population: 80% herd immunity a few months from onset would otherwise be overly optimistic, 
compared to other de novo pandemics; e.g., (Donaldson et al., 2009). On the other hand, an occult herd 
immunity (i.e. not accompanied by symptoms) is consistent with undocumented infection and rapid 
dissemination (Li et al., 2020). Note that this way of characterising the spread of a virus depends upon 
many variables (in this model, two factors and three parameters). And can vary from country to country. 
Repeating the above analysis for China gives a much higher an initial or basic reproduction rate, which is 
consistent with empirical reports (Steven et al., 2020). 
 
25 The basic reproduction ratio is a constant that scores the spread of a contagion in a susceptible population. This 
corresponds to the effective reproduction ratio at the beginning of the outbreak, when everybody is susceptible. See 
Figure 12. 
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FIGURE 12 
Figure 12: effective reproduction ratio. This figure plots the predicted death rates for the United Kingdom from 
Figure 6 and the concomitant fluctuations in the effective reproduction rate (R) and herd immunity. The blue lines 
represent the posterior expectations while the shaded areas correspond to 90% credible intervals.  
This concludes our characterisation of projections for what is likely to happen and what could happen under 
different scenarios for a particular country. In the final section, we revisit the confidence with which these 
posterior predictive projections can be made. 
Predictive Validity 
Variational approaches—of the sort described in this technical report—use all the data at hand to furnish 
statistically efficient estimates of model parameters and evidence. This contrasts with alternative 
approaches based on cross-validation. In the cross-validation schemes, model evidence is approximated by 
cross-validation accuracy. In other words, the evidence for a model is scored by the log likelihood that some 
withheld or test data can be explained by the model. Although model comparison based upon a variational 
evidence bound renders cross-validation unnecessary, one can apply the same procedures to demonstrate 
predictive validity. Figure 13 illustrates this by fitting partial timeseries from one country (Italy) using the 
empirical priors afforded by the parametric empirical Bayesian analysis. These partial data comprise the 
early phase of new cases. If the model has predictive validity, the ensuing posterior predictive density 
should contain the data that was withheld during estimation. Figure 13 presents an example of forward 
prediction over a 10-day period that contains the peak death rate. In this example, the withheld data are 
largely within the 90% credible intervals, speaking to the predictive validity of the generative model. There 
are two caveats here: first, similar analyses using very early timeseries from Italy failed to predict the peak, 
because of insufficient (initial) constraints in the data. Second, the credible intervals probably suffer from 
the well-known overconfidence problem in variational Bayes, and the implicit mean field approximation 
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(MacKay, 2003)26.  
 
FIGURE 13 
Figure 13: predictive validity. This figure uses the same format as Figure 7; however, here, the posterior estimates 
are based upon partial data, from early in the timeseries for an exemplar country (Italy). These estimates were obtained 
under (parametric) empirical Bayesian priors. The red dots show outcomes that were not used to estimate the expected 
trajectories (and credible intervals). This example illustrates the predictive validity of the estimates for a 10-day period 
following the last datapoint, which capture the rise to the peak of new cases. 
 
26 Note further that the credible intervals can include negative values. This is an artefact of the way in which the 
intervals are computed: here, we used a first-order Taylor expansion to propagate uncertainty about the parameters 
through to uncertainty about the outcomes. However, because this generative model is non-linear in the parameters, 
high-order terms are necessarily neglected. 
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Conclusions 
We have rehearsed variational procedures for the inversion of a generative model of a viral epidemic—and 
have extended this model using hierarchical Bayesian inference (parametric empirical Bayes) to deal with 
the differential responses of each country, in the context of a worldwide pandemic. The utility of such 
modelling is self-evident: one can predict, with a quantified degree of confidence, what may happen in the 
near future. For example, under the posterior beliefs based upon data at the time of writing, one can sketch 
a narrative for what people in London may experience over the forthcoming weeks. This narrative would 
be something like the following: 
“Based on current data, reports of new cases in London are expected to peak on April 5, followed by a 
peak in death rates around April 10 (Good Friday). At this time, critical care unit occupancy should peak, 
approaching—but not exceeding—capacity, based on current predictions and resource availability. At the 
peak of death rates, the proportion of people infected (in London) is expected to be about 32%, which 
should then be surpassed by the proportion of people who are immune at this time. Improvements should 
be seen by May 8, shortly after the May bank holiday, when social distancing will be relaxed. At this time 
herd immunity should have risen to about 80%, about 12% of London's population will have been tested. 
Just under half of those tested will be positive. By June 12, death rates should have fallen to low levels with 
over 90% of people being immune and social distancing will no longer be a feature of daily life.” 
Clearly, this narrative is entirely conditioned on the generative model used to make these predictions (e.g., 
the assumption of lasting immunity, which may or may not be true). The narrative is offered in a deliberately 
definitive fashion to illustrate the effect of resolving uncertainty about what will happen. It has been argued 
that many deleterious effects of the pandemic are mediated by uncertainty. This is probably true at both a 
psychological level—in terms of stress and anxiety (Davidson, 1999; McEwen, 2000; Peters et al., 2017)—
and at an economic level in terms of ‘loss of confidence’ and ‘uncertainty about markets’. Put simply, the 
harmful effects of the coronavirus pandemic are not just what will happen but the effects of the uncertainty 
about what will happen. This is a key motivation behind procedures that quantify uncertainty, above and 
beyond being able to evaluate the evidence for different hypotheses about what will happen. 
One aspect of this is reflected in rhetoric such as “there is no clear exit strategy”. It is reassuring to note 
that, if one subscribes to the above model, there is a clear exit strategy inherent in the self-organised 
mitigation27 afforded by herd immunity. For example, within a week of the peak death rate, there should be 
sufficient herd immunity to preclude any resurgence of infections in, say, London. The term ‘self-organised’ 
is used carefully here. This is because we are part of this process, through the effect of social distancing on 
our location, contact with infected people and subsequent dissemination of COVID-19. In other words, this 
formulation does not preclude strategic (e.g., nonpharmacological) interventions; rather, it embraces them 
as part of the self-organising ensemble dynamics. 
 
27 This technical report does not distinguish between mitigation and suppression: in the generative model under 
consideration, both go hand-in-hand. 
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Outstanding issues 
There are several outstanding issues that present themselves: 
The generative model—at both the first and second level—needs to be explored more thoroughly. At the 
first level, this may entail the addition of other factors; for example, splitting the population into age groups 
or different classes of clinical vulnerability. Procedurally, this should be fairly simple, by specifying the 
DCM parameters for each age group (or cohort) separately and precluding transitions between age groups 
(or cohorts). One could also consider the fine graining of states within each factor. For example, making a 
more careful distinction between being in and not in critical care (e.g., being in self-isolation, being in a 
hospital, community care home, rural or urban location and so on). At the between city or country level, 
the parameters of the general linear model could be easily extended to include a host of demographic and 
geographic independent variables. Finally, it would be fairly straightforward to use increasingly fine-
grained outcomes, using regional timeseries, as opposed to country timeseries (these data are currently 
available from: https://github.com/CSSEGISandData/COVID-19). 
Another plausible extension to the hierarchical model is to include previous outbreaks of MERS and SARS 
(Middle East and Severe Acute Respiratory Syndrome, respectively) in the model. This would entail 
supplementing the timeseries with historical (i.e., legacy) data and replicating the general linear model for 
each type of virus. In effect, this would place empirical priors or constraints on any parameter that shares 
characteristics with MERS-CoV and SARS-CoV. 
In terms of the model parameters—as opposed to model structure—more precise knowledge about the 
underlying causes of an epidemic will afford more precise posteriors. In other words, more information 
about the DCM parameters can be installed through adjusting the prior expectations and variances. The 
utility of these adjustments would then be assessed in terms of model evidence. This may be particularly 
relevant as reliable data about bed occupancy, proportion of people recovered, etc becomes available. 
A key aspect of the generative model used in this technical report is that it precludes any exogenous 
interventions of a strategic sort. In other words, the things that matter are built into the model and estimated 
as latent causes. However, prior knowledge about fluctuating factors, such as closing schools or limiting 
international air flights, could be entered by conditioning the DCM parameters on exogenous inputs. This 
would explicitly install intervention policies into the model. Again, these conditions would only be licensed 
by an increase in model evidence (i.e., through comparing the evidence for models with and without some 
structured intervention). This may be especially important when it comes to modelling future interventions, 
for example, a ‘sawtooth’ social distancing protocol. A simple example of this kind of extension would be 
including a time dependent increase in the capacity for testing: at present, constraints on testing rates are 
assumed to be constant. 
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A complementary approach would be to explore models in which social distancing depends upon variables 
that can be measured or inferred reliably (e.g., the rate of increase of people testing positive) and optimise 
the parameters of the ensuing model to minimise cumulative deaths. In principle, this should provide an 
operational equation that could be regarded as an adaptive (social distancing) policy, which accommodates 
as much as can be inferred about the epidemiology as possible. 
A key outstanding issue is the modelling of how one region (or city) affects another—and how the outbreak 
spreads from region to region. This may be an important aspect of these kinds of models; especially when 
it comes to modelling second waves as ‘echoes’ of infection, which are reflected back to the original 
epicentre. As noted above, the ability of these echoes to engender a second wave may be sensitively 
dependent on the herd immunity established during the first episode. Herd immunity is therefore an 
important (currently latent or unobserved) state. This speaks to the importance of antibody testing in 
furnishing empirical constraints on herd immunity. In turn, this motivates antibody testing, even if the 
specificity and sensitivity of available tests are low. Sensitivity and specificity are not only part of 
generative models, they can be estimated along with the other model parameters. In this setting, the role of 
antibody testing would be to provide data for population modelling and strategic advice—not to establish 
whether any particular person is immune or not (e.g., to allow them to go back to work). 
Finally, it would be useful to assess the construct validity of the variational scheme adopted in dynamic 
causal modelling, in relation to schemes that do not make mean field approximations. These schemes 
usually rely upon some form of sampling (e.g., Markov Chain Monte Carlo sampling) and cross-validation. 
Cross-validation accuracy can be regarded as a useful but computationally expensive proxy for model 
evidence and is the usual way that modellers perform automatic Bayesian computation. Given the 
prevalence of these sampling based (non-variational) schemes, it would be encouraging if both approaches 
converged on roughly the same predictions. The aim of this technical report is to place variational schemes 
on the table, so that construct validation becomes a possibility in the short-term future. 
 
Software note 
The figures in this technical report can be reproduced using annotated (MATLAB) code that is available as 
part of the free and open source academic software SPM (https://www.fil.ion.ucl.ac.uk/spm/). This software 
package has a relatively high degree of validation; being used for the past 25 years by over 5000 scientists 
in the neurosciences. The routines are called by a demonstration script that can be invoked by typing >> 
DEM_COVID. At the time of writing, these routines are undergoing software validation in our internal 
source version control system - that will be released in the next public release of SPM (and via GitHub at 
https://github.com/spm/). 
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